Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Percheron Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Biotron targets coronavirus, shares jump
Health & Biotech
Health Kick Podcast: Novel gene targeting therapies, protein disruptors and why ANP’s recent trial success have investors buzzing
Health & Biotech
Health: Antisense’s anti-muscular dystrophy drug just took a big step
Health & Biotech
Biotech exec pay — are they delivering returns that equal their pay packets?
Health & Biotech
Dr Boreham’s Crucible: Can Phylogica finally make magic happen after nearly 15 years of trying?
News
Trading Places: Here are this week’s substantial holder movements
Health & Biotech
Health: FDA approval is eye candy for Visioneering’s kiddie contact lens
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
News
Lunchtime ASX small cap wrap: Who’s blaming the umpiring today?
Stockhead TV
Video: 90 Seconds With… Mark Diamond, Antisense Therapeutics
Health & Biotech
Check-up: Medicinal cannabis investment puts an energy company in top spot
News
Lunchtime ASX small cap wrap: Who’s pointing the finger today?
Health & Biotech
Health: Cynata has finally scored that Fujifilm deal; shares climb 27pc
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Antisense wants to conquer the less crowded DMD market
News